# FDA Inspection 616111 - Sher Institute for Reproductive Medicine New Jersey P.A. - September 29, 2009

Source: https://www.keypedia.com/records/fda_inspections/sher-institute-for-reproductive-medicine-new-jersey-pa/6f954c05-76d7-4c0d-a749-ffbd8c2622d5
Source feed: FDA_Inspections

> FDA Inspection 616111 for Sher Institute for Reproductive Medicine New Jersey P.A. on September 29, 2009. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 616111
- Company Name: Sher Institute for Reproductive Medicine New Jersey P.A.
- Inspection Date: 2009-09-29
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 713751 - 2011-03-14](https://www.keypedia.com/records/fda_inspections/sher-institute-for-reproductive-medicine-new-jersey-pa/05499d66-49e3-4336-ba93-73344dcb2f8d)

Company: https://www.keypedia.com/companies/sher-institute-for-reproductive-medicine-new-jersey-pa/08f8bf03-5ffe-4f7c-bcb1-95ca8d18b577

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d